{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T22:55:04Z","timestamp":1791240904247,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.bmc.2022.116766","type":"journal-article","created":{"date-parts":[[2022,4,22]],"date-time":"2022-04-22T20:50:41Z","timestamp":1650660641000},"page":"116766","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Evaluation of potential anticonvulsant fluorinated N-benzamide enaminones as T-type Ca2+ channel blockers"],"prefix":"10.1016","volume":"65","author":[{"given":"Isis J.","family":"Amaye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice L.","family":"Jackson-Ayotunde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Martin-Caraballo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.bmc.2022.116766_b0005","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.3390\/ijerph15081784","article-title":"6 Hz Active Anticonvulsant Fluorinated N-Benzamide Enaminones and Their Inhibitory Neuronal Activity","volume":"15","author":"Amaye","year":"2018","journal-title":"Int J Environ Res Public Health"},{"issue":"3","key":"10.1016\/j.bmc.2022.116766_b0010","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1021\/jm901563p","article-title":"Synthesis and anticonvulsant activities of (R)-N-(4'-substituted)benzyl 2-acetamido-3-methoxypropionamides","volume":"53","author":"Salome","year":"2010","journal-title":"J Med Chem"},{"issue":"3","key":"10.1016\/j.bmc.2022.116766_b0015","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1124\/jpet.110.173740","article-title":"A Substituted Anilino Enaminone Acts as a Novel Positive Allosteric Modulator of GABAA Receptors in the Mouse Brian","volume":"336","author":"Wang","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"10.1016\/j.bmc.2022.116766_b0020","doi-asserted-by":"crossref","first-page":"470","DOI":"10.3390\/biomedicines9050470","article-title":"Pharmacological and Therapeutic Approaches in the Treatment of Epilepsy","volume":"9","author":"Ghosh","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.bmc.2022.116766_b0025","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1111\/epi.13406","article-title":"Drug-resistant epilepsy in adults: Outcome trajectories after failure of two medications","volume":"57","author":"Choi","year":"2016","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.bmc.2022.116766_b0030","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1124\/pr.120.019539","article-title":"Drug Resistance in Epilepsy: Clinical Impact, Potential Mechanisms, and New Innovative Treatment Options","volume":"72","author":"L\u00f6scher","year":"2020","journal-title":"Pharmacol Rev"},{"issue":"2","key":"10.1016\/j.bmc.2022.116766_b0035","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00424-009-0772-x","article-title":"Role of voltage-gated calcium channels in epilepsy","volume":"460","author":"Zamponi","year":"2010","journal-title":"Pflugers Arch"},{"issue":"1","key":"10.1016\/j.bmc.2022.116766_b0040","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1152\/physrev.00018.2002","article-title":"Molecular physiology of low-voltage-activated t-type calcium channels","volume":"83","author":"Perez-Reyes","year":"2003","journal-title":"Physiol Rev"},{"issue":"6","key":"10.1016\/j.bmc.2022.116766_b0045","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1074\/jbc.M008215200","article-title":"Molecular and functional characterization of a family of rat brain T-type calcium channels","volume":"276","author":"McRory","year":"2001","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.bmc.2022.116766_b0050","doi-asserted-by":"crossref","first-page":"475","DOI":"10.4161\/chan.4.6.14106","article-title":"Contributions of T-type calcium channel isoforms to neuronal firing","volume":"4","author":"Cain","year":"2010","journal-title":"Channels (Austin)"},{"issue":"1","key":"10.1016\/j.bmc.2022.116766_b0055","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s13041-021-00813-7","article-title":"Modeling temperature- and Cav3 subtype-dependent alterations in T-type calcium channel mediated burst firing","volume":"14","author":"Fernandez","year":"2021","journal-title":"Mol Brain"},{"issue":"9","key":"10.1016\/j.bmc.2022.116766_b0060","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.1523\/JNEUROSCI.22-09-03645.2002","article-title":"Upregulation of a T-type Ca2+ channel causes a long-lasting modification of neuronal firing mode after status epilepticus","volume":"22","author":"Su","year":"2002","journal-title":"J Neurosci"},{"issue":"2","key":"10.1016\/j.bmc.2022.116766_b0065","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/ana.10607","article-title":"Association between genetic variation of CACNA1H and childhood absence epilepsy","volume":"54","author":"Chen","year":"2003","journal-title":"Ann Neurol"},{"issue":"19","key":"10.1016\/j.bmc.2022.116766_b0070","doi-asserted-by":"crossref","first-page":"4844","DOI":"10.1523\/JNEUROSCI.0847-05.2005","article-title":"Functional characterization and neuronal modeling of the effects of childhood absence epilepsy variants of CACNA1H, a T-type calcium channel","volume":"25","author":"Vitko","year":"2005","journal-title":"J Neurosci"},{"issue":"15","key":"10.1016\/j.bmc.2022.116766_b0075","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1021\/jm00093a012","article-title":"Synthesis and anticonvulsant activity of enaminones","volume":"35","author":"Edafiogho","year":"1992","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2022.116766_b0080","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1016\/j.bmc.2013.03.036","article-title":"Enaminones 11. An Examination of Some Ethyl Ester Enaminone Derivatives as Anticonvulsant Agents","volume":"21","author":"Alexander","year":"2013","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2022.116766_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.tet.2021.131984","article-title":"Enaminones as building blocks in drug development: Recent advances","volume":"83","author":"Amaye","year":"2021","journal-title":"Tetrahedron"},{"issue":"1302","key":"10.1016\/j.bmc.2022.116766_b0090","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1098\/rspb.1990.0084","article-title":"Novel cell lines display properties of nociceptive sensory neurons","volume":"241","author":"Wood","year":"1990","journal-title":"Proc Biol Sci"},{"issue":"5","key":"10.1016\/j.bmc.2022.116766_b0095","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s13365-017-0545-9","article-title":"Regulation of T-type Ca2+ channel expression by herpes simplex virus-1 infection in sensory-like ND7 cells","volume":"23","author":"Zhang","year":"2017","journal-title":"J Neurovirol"},{"issue":"Pt 2","key":"10.1016\/j.bmc.2022.116766_b0100","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1113\/jphysiol.2001.012839","article-title":"Stimulation of recombinant Ca(v)3.2, T-type, Ca (2+) channel currents by CaMKIIgamma(C)","volume":"538","author":"Wolfe","year":"2002","journal-title":"J Physiol"},{"issue":"3","key":"10.1016\/j.bmc.2022.116766_b0105","doi-asserted-by":"crossref","first-page":"C576","DOI":"10.1152\/ajpcell.00115.2010","article-title":"Leukemia inhibitory factor regulates trafficking of T-type Ca2+ channels","volume":"300","author":"Dey","year":"2011","journal-title":"Am J Physiol Cell Physiol"},{"issue":"12","key":"10.1016\/j.bmc.2022.116766_b0110","first-page":"4171","article-title":"Comparison of the Ca2 + currents induced by expression of three cloned alpha1 subunits, alpha1G, alpha1H and alpha1I, of low-voltage-activated T-type Ca2 + channels Eur","volume":"11","author":"Kl\u00f6ckner","year":"1999","journal-title":"J Neurosci"},{"issue":"4","key":"10.1016\/j.bmc.2022.116766_b0115","doi-asserted-by":"crossref","first-page":"241","DOI":"10.4236\/ojpc.2019.94015","article-title":"Molecular Docking Studies on Anticonvulsant Enaminones Inhibiting Voltage-Gated Sodium Channels","volume":"9","author":"Fang","year":"2019","journal-title":"Open J Phys Chem"},{"key":"10.1016\/j.bmc.2022.116766_b0120","doi-asserted-by":"crossref","DOI":"10.1177\/1744806916646111","article-title":"Neuronal cell lines as model dorsal root ganglion neurons: A transcriptomic comparison","volume":"12","author":"Yin","year":"2016","journal-title":"Mol Pain"},{"issue":"2","key":"10.1016\/j.bmc.2022.116766_b0125","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1523\/JNEUROSCI.22-02-00396.2002","article-title":"Differential inhibition of T-type calcium channels by neuroleptics","volume":"22","author":"Santi","year":"2002","journal-title":"J Neurosci"},{"issue":"3","key":"10.1016\/j.bmc.2022.116766_b0130","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1124\/mol.108.051664","article-title":"Mechanisms and functional significance of inhibition of neuronal T-type calcium channels by isoflurane","volume":"75","author":"Orestes","year":"2009","journal-title":"Mol Pharmacol"},{"issue":"5","key":"10.1016\/j.bmc.2022.116766_b0135","doi-asserted-by":"crossref","first-page":"G706","DOI":"10.1152\/ajpgi.00437.2009","article-title":"T-type Ca(2+) channel modulation by otilonium bromide","volume":"298","author":"Strege","year":"2010","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"1\u20133","key":"10.1016\/j.bmc.2022.116766_b0140","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S0014-5793(02)03341-0","article-title":"Alternative splicing of the rat Ca(v)3.3 T-type calcium channel gene produces variants with distinct functional properties","volume":"528","author":"Murbarti\u00e1n","year":"2002","journal-title":"FEBS Lett"},{"issue":"6","key":"10.1016\/j.bmc.2022.116766_b0145","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1523\/JNEUROSCI.19-06-01895.1999","article-title":"Differential distribution of three members of a gene family encoding low voltage-activated (T-type) calcium channels","volume":"19","author":"Talley","year":"1999","journal-title":"J Neurosci"},{"issue":"2","key":"10.1016\/j.bmc.2022.116766_b0150","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0306-4522(02)00936-3","article-title":"Immunological characterization of T-type voltage-dependent calcium channel CaV3.1 (alpha 1G) and CaV3.3 (alpha 1I) isoforms reveal differences in their localization, expression, and neural development","volume":"117","author":"Yunker","year":"2003","journal-title":"Neuroscience"},{"issue":"83","key":"10.1016\/j.bmc.2022.116766_b0155","article-title":"Ontogenic Changes and Differential Localization of T-type Ca(2+) Channel Subunits Cav3.1 and Cav3.2 in Mouse Hippocampus and Cerebellum","volume":"10","author":"Aguado","year":"2016","journal-title":"Front Neuroanat"},{"issue":"Pt 1","key":"10.1016\/j.bmc.2022.116766_b0160","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1113\/jphysiol.2005.086579","article-title":"Different kinetic properties of two T-type Ca2+ currents of rat reticular thalamic neurones and their modulation by enflurane","volume":"566","author":"Joksovic","year":"2005","journal-title":"J Physiol"},{"issue":"6","key":"10.1016\/j.bmc.2022.116766_b0165","doi-asserted-by":"crossref","first-page":"447","DOI":"10.4161\/chan.4.6.12870","article-title":"T-type calcium channel expression and function in the diseased heart","volume":"4","author":"Cribbs","year":"2010","journal-title":"Channels (Austin)"},{"issue":"18","key":"10.1016\/j.bmc.2022.116766_b0170","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.2174\/138161206777585184","article-title":"The role of T-type calcium channels in epilepsy and pain","volume":"12","author":"Nelson","year":"2006","journal-title":"Curr Pharm Des"},{"issue":"2","key":"10.1016\/j.bmc.2022.116766_b0175","doi-asserted-by":"crossref","first-page":"G249","DOI":"10.1152\/ajpgi.00022.2005","article-title":"Effect of mibefradil on sodium and calcium currents","volume":"289","author":"Strege","year":"2005","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.bmc.2022.116766_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.107966","article-title":"Mechanisms of action of currently used antiseizure drugs","volume":"168","author":"Sills","year":"2020","journal-title":"Neuropharmacology"},{"issue":"13","key":"10.1016\/j.bmc.2022.116766_b0185","doi-asserted-by":"crossref","first-page":"4842","DOI":"10.1523\/JNEUROSCI.18-13-04842.1998","article-title":"On the action of the anti-absence drug ethosuximide in the rat and cat thalamus","volume":"18","author":"Leresche","year":"1998","journal-title":"J Neurosci"},{"issue":"12","key":"10.1016\/j.bmc.2022.116766_b0190","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1080\/13543776.2018.1541982","article-title":"T-type calcium channel blockers: a patent review (2012\u20132018)","volume":"28","author":"Nam","year":"2018","journal-title":"Expert Opin Ther Pat"},{"key":"10.1016\/j.bmc.2022.116766_b0195","article-title":"T-type calcium channel blockers that attenuate thalamic burst firing and suppress absence seizures","volume":"4(121):121ra19","author":"Tringham","year":"2012","journal-title":"Sci Transl Med"},{"issue":"12","key":"10.1016\/j.bmc.2022.116766_b0200","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1111\/bph.13910","article-title":"Inhibition of human N- and T-type calcium channels by an ortho-phenoxyanilide derivative, MONIRO-1","volume":"175","author":"McArthur","year":"2018","journal-title":"Br J Pharmacol"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089622001584?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089622001584?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T01:17:59Z","timestamp":1760836679000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089622001584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":40,"alternative-id":["S0968089622001584"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2022.116766","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of potential anticonvulsant fluorinated N-benzamide enaminones as T-type Ca2+ channel blockers","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2022.116766","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116766"}}